Pulmonary Function in Older Patients With Ventricular Septal Defect - 13/05/20
, Marie Maagaard, MD, PhD a, b, #, Nicolai Boutrup a, b, #, Vibeke Elisabeth Hjortdal, MD, PhD, DMSc a, b, #Highlights |
• | Adults with surgically corrected isolated VSDs reveal pulmonary dysfunction. |
• | Dynamic pulmonary function is impaired in corrected VSDs. |
• | Corrected VSDs reveal abnormal lung function in the smaller airway sections. |
• | Our findings mandating continued follow-up of VSD patients in expert ACHD clinics. |
Résumé |
To better understand the evolvement of the pulmonary dysfunction in the aging ventricular septal defect (VSD) patient, we invited adult patients with a congenital VSD and healthy age- and gender-matched controls for static and dynamic spirometry, impulse oscillometry, multiple breath washout, and diffusion capacity for carbon monoxide testing. Primary outcome was forced expiratory volume in 1 second. In total, 30 patients with a surgically corrected VSD (mean age 51 ± 8 years), 30 patients with a small, unrepaired VSD (mean age 55 ± 1 years), and 2 groups of 30 age- and gender-matched, healthy controls (mean age 52 ± 9 years and 55 ± 10 years, respectively) were included. Median age of radical surgery was 6.3 (total range: 1.4 to 54) years and median follow-up after surgery was 40 years (total range: 3.4 to 54). Compared with healthy matched controls, surgically corrected VSD patients had lower forced expiratory volume in 1 second, 87 ± 19% versus 105 ± 14% of predicted, p <0.01, lower forced vital capacity, 92 ± 16% versus 107 ± 13% of predicted, p <0.01, and lower peak expiratory flow, 100 ± 21% versus 122 ± 16% of predicted, p <0.01. Furthermore, corrected VSD patients revealed increased airway resistance in the small airways, 30 ± 22% versus 15 ± 14% of total resistance, p <0.01, and reduced diffusion capacity, 84 ± 12% versus 101 ± 11%, p <0.01. Patients with a small, unrepaired VSD had comparable pulmonary function to their matched controls. In conclusion, VSD patients 40 years of age or older demonstrated significant impaired pulmonary function in terms of reduced dynamic pulmonary function, increased airway resistance in the small airways, and reduced diffusion capacity up to 54 years after defect closure compared with healthy age- and gender-matched controls.
Le texte complet de cet article est disponible en PDF.Plan
| Source of funding: Karen Elise Jensen's Fund, Aarhus, Denmark; Dagmar Marshall's Fund, Aarhus, Denmark; Aarhus University, Aarhus, Denmark. |
|
| Location where the work has been performed: Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark. |
|
| Protocol identifier at Clinical Trials: NCT03684161. |
|
| IRB Approval: Chart 1-16-02-290-18. |
|
| Committee on Biomedical Research Ethics of the Central Denmark Region: Chart 1-10-72-185-18. |
Vol 125 - N° 11
P. 1710-1717 - juin 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
